K,I agree with your "sloppy due diligence" concept. Remember,...

K,

I agree with your "sloppy due diligence" concept. Remember, the sloppy work with regard the PRIME spinoff, which was rejected by ASIC? Why haven't we heard about that?

And what about the sloppy due diligence with regard BioInquire which cost us a cool $12m, not to mention the bonuses paid for "gain on bargain purchase", which turned out to be a "huge loss on not such a bargain purchase".

The directors' record speaks for itself.

I think we'd be silly, or worse, to ignore the possibility that our leaders screw it up. History suggests a high probability.

And I think we'd be silly, or worse, to ignore the possibility that the Chinese would try and steal our IP. If they don't try, what does that say about the IP??? That it is not worth stealing? That's something far, far worse to contemplate.